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ABSTRACT
Although there is wide variation in the prevalence of 
nasal allergies internationally, the extent to which this 
is due to variation in etiological factors is not known. 
The purpose of the present study was to define the 
relative importance of atopy and other risk factors for 
nasal allergies, including hayfever, among young 
adults in Melbourne. The subjects were participants in 
the second phase of the European Community 
Respiratory Health Survey; 876 adults between 20 and 
45 years of age completed a detailed respiratory 
questionnaire, 745 had skin prick testing with 
common aeroallergens and 675 underwent 
methacholine challenge. Total and allergen-specific 
IgE levels were measured in 701 and 693 subjects by 
radioimmunoassay and RAST, respectively. Nasal 
allergies, including hayfever, were reported by 47.5% 
of randomly selected participants. Females, non-
smokers, subjects with a family history of allergies, 
those with current asthma, a history of eczema and 
nasal symptoms induced by dust, pollen or food were 
significantly more likely to have nasal allergies. Oral 
antihistamines had been used by 45.7% of those 
reporting nasal allergies and 12.4% had received 
allergen immunotherapy. The risk of nasal allergies, 
including hayfever, was increased 6.1-fold by atopy, 
particularly by positive skin tests to outdoor allergens
such as Birch, Timothy grass, plantain, olive, 
Cladosporium and Rye grass pollen. Total serum IgE 
was significantly higher in subjects reporting nasal 
allergies than in those who did not report such 
allergies. There were significant trends in the 
prevalence of nasal allergies with increasing titers of 
specific IgE directed against all allergens tested. In 
conclusion, the significant independent risk factors for 
nasal allergies, including hayfever, in young adults 
were atopy, particularly sensitization to Timothy grass, 
house dust mites and plantain, current asthma, not 
smoking, a history of eczema and female gender. 
Future research needs to distinguish between hayfever 
and perennial allergic rhinitis, which was not possible 
in the present study.
Key words: atopy, bronchial hyperreactivity, hayfever, 
immunoglobulin E, nasal allergies, questionnaires, 
skin prick tests.
INTRODUCTION
Allergic rhinitis and hayfever are common and distressing 
disorders in many Western societies. Hayfever was 
reported by 10.3% of respondents in the Australian 
1989-90 National Health Survey,1 the second most 
common chronic condition after visual disorders. 
Furthermore, the prevalence of hayfever is increasing in 
Australia. In 1991-93, 41.3% of a cohort of Tasmanian 
adults reported hayfever, compared with 19.2% of their 
parents in 1968.2 Although allergic rhinitis is not by itself 
life-threatening, the symptoms can have profound effects 
upon the quality of life3 and result in substantial loss of 
productivity and absenteeism from school and from work.
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 The prevalence of allergic rhinitis is also high in the 
United Kingdom, where distinct patterns have been 
described in the population. A survey of adults registered 
with a London general practice found that the prevalence 
of rhinitis was at least 24%.4 Seasonal symptoms were 
reported by 3% of respondents, perennial symptoms were 
reported by 13% and 8% had perennial symptoms with 
seasonal exacerbations. Another survey of a Nottingham 
general practice found that 29% of adults claimed to 
have had hayfever within the preceding 2 years.5 
 Until now there has been little published information 
comparing the prevalence of allergic rhinitis or hayfever 
in adults between countries utilizing standardized 
epidemiological methods. This gap in our knowledge is 
being addressed by the European Community Respiratory 
Health Survey (ECRHS) in over 50 centers around the 
world.b The first phase of the ECRHS7 has now confirmed 
that nasal allergies are more common in Australia 
(40.9%), New Zealand (35.1-37.8%), US (39.4%), 
France (28.1-30.3%), Britain (23.6-28.3%) and 
Scandinavia (19.5-22.3%) than in East Germany (13.4%) 
or Spain (12.1-17.6%). The ECRHS is also investigating 
risk factors that may explain the international variation in 
the prevalence of rhinitis or hayf ever. 
  Previously reported risk factors for allergic rhinitis and 
hayfever include Asian ethnicity,8 family history of 
allergies,9,10 season of birth, pollen exposure11 and atopy 
to aeroallergens. Recognized trigger factors include dust, 
pollen, animals, food, viral infections, odors and 
emotional stress. There are also associations between 
rhinitis and eczema, asthma4 or bronchial hyperreactivity 
(BHR) to methacholine.12 The aim of the present study was 
to define the most important risk factors for nasal allergies 
and hayfever among young adults in Melbourne, 
Australia. This study was conducted as part of the ECRHS 
and used objective measurements of atopy and BHR.
METHODS
Subjects
The subjects were participants in the second phase of the 
ECRHS in Melbourne. The full details of the sampling 
protocol have been described elsewhere;6,13 briefly, 4500 
adults between 20 and 44 years of age were randomly 
selected from the electoral roll. Postal questionnaires 
were returned by 3200 (72%) subjects in the first phase of 
the ECRHS. A random sample of 553 young adults and a 
sample of 204 with symptoms of asthma attended the 
laboratory for testing. The study was approved by the 
Ethics Review Committee of the Alfred Hospital.
Questionnaire
Participants completed the detailed second phase ECRHS 
questionnaire administered by one of three trained 
interviewers. The background and validity of this 
questionnaire have been described elsewhere.6 Briefly, 
the questionnaire covered history of allergies, family 
history, home environment, pets, nasal symptoms, trigger 
factors, smoking, demographic information, medications 
and management. The questionnaire was completed by 
757 participants in the laboratory and a further 119 
participants by telephone interview.
Lung function testing
Lung function was measured with a computerized Fleisch 
number 3 pneumotach connected to a Hewlett Packard 
(Waltham, MA, USA) lung function analyzer. Initial FEV1, 
was recorded as the best of five blows that met American 
Thoracic Society criteria. Methacholine (ProvocholineTM; 
Hoffman La Roche, Basel, Switzerland) was delivered by a 
Mefar 3B dosimeter (Mefar srl, Bovezzi, Italy) until FEV1, 
fell by 20% from the initial value or up to a cumulative
dose of 2mg (10μmol). The challenge protocol has
been described in detail elsewhere.6,14 Methacholine 
challenge tests were completed by 675 subjects (89% of 
those who attended the laboratory).
Skin prick testing
Skin prick testing for allergies was performed on the volar 
surface of the forearm, using PhazetsTM (Kabi-Pharmacia, 
Uppsala, Sweden), which are lancets precoated with a 
standard amount of allergen. The ECRHS allergen panel 
f D rmatophagoides pteronyssinus, cat, Timothy grass, 
birch, olive, Parietaria, ragweed, Cladosporium and 
Alternaria was used, together with positive (histamine) 
and negative (uncoated lancet) controls. In addition, 
standard extracts of the local allergens rye grass pollen 
and plantain (Hollister-Stier, Spokane, WA, USA) were 
used with conventional lancets. Wheals were measured 
after 15min. A maximum diameter of 3mm or greater 
was considered positive. Valid skin prick tests were 
performed on 745 subjects (98% of those who attended 
the laboratory).
In vitro allergy tests
S rum was obtained from 701 subjects (93% of those 
who attended the laboratory). Total serum IgE was 
measured by radioimmunoassay using the standard CAP
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system (Kabi-Pharmacia). Allergen-specific IgE was 
measured in 693 specimens by radioallergosorbent 
tests (RAST). The immunoCAP used were Timothy 
grass, rye grass, D. pteronyssinus, ragweed, plantain, 
Cladosporium, Alternaria and cat. Results are expressed 
as RAST classes 0-6, with cutpoints of 0.35, 0.7, 3.5, 
17.5, 50 and 100kUA/L.
Definitions
The principal outcome of interest was a positive response 
to the question 'do you have any nasal allergies including 
"hayfever". Bronchial hyperreactivity was defined as a 
provocative dose causing a 20% reduction (PD20) in the 
forced expiratory volume in one second (FEV1) <2mg 
methacholine. Atopy was defined as a positive reaction to 
any allergen, in the context of a positive histamine control 
and a negative reaction to the uncoated lancet. Current 
asthma was defined as the combination of wheezing in the 
past 12 months and BHR.15
Statistical analysis
Data from the questionnaires, lung function tests and skin 
prick tests were professionally entered and verified. 
Range and logic checks were performed to confirm the 
validity of the data. All analyses were conducted using the 
SAS computing package.16 Because total serum IgE levels 
followed a skewed distribution, the data were log 
transformed prior to further analysis. Association between
categorical variables was assessed by the χ2 test or
Fisher's exact test and comparisons of continuous 
variables were made by the Student's t-test. Confidence 
intervals (Cl) for proportions were estimated by the 
normal approximation to the binomial distribution. 
Cohen's k was used to assess agreement beyond that
expected by chance and McNemar's χ2 was used to
assess differences in the prevalence of positive results 
from paired tests. Odds ratios and 95% Cl were 
calculated by the Mantel-Haenszel method.17 A 
multivariate model of nasal allergies was fitted with 
stepwise multiple logistic regression. A P value <0.05 
was considered statistically significant.
RESULTS
Description of subjects
The 876 subjects who completed the questionnaire in the 
second phase of the ECRHS had a mean age of 34.2
years. There was a slight female preponderance (52.9% 
female, 47.1% male). Nasal allergies, including hayfever, 
were reported by 467 (53.3%) of all respondents and 
317 (47.5%) of the random sample. Most of those 
reporting nasal allergies probably did have hayfever; 
376 (42.9%) reported pollen-induced symptoms (i. e. a 
runny or stuffy nose or sneezing when near trees, grass, 
flowers or pollen, especially in the spring). Bronchial 
hyperreactivity was demonstrated by 240 (35.6%) of the 
675 subjects who completed the methacholine challenge 
test. The definition of current asthma was satisfied by 172 
subjects, 25.5% of those who were challenged.
Atopy
Atopy was present in 420 (56.4%) of the 745 subjects 
wh  underwent skin prick testing. The proportions (and 
95% Cl) who reacted to specific allergens on skin test are
summarized in Table 1. Geometric mean (±geometric
SD) total IgE was 48.9±7.5kU/L and 80% of non-atopic
subjects had levels below 142kU/L. The proportion of 
subjects with detectable allergen specific IgE by RAST 
is also summarized in Table 1. There were significant 
(P<0.0001) relationships between total IgE levels and
RAST class for all allergens tested. Agreement between
the results of skin prick tests to most allergens and each 
corresponding RAST was generally good (Table 1), 
although skin prick tests were significantly more sensitive. 
For ragweed, there was no agreement beyond chance 
and, surprisingly, RAST was more sensitive than the skin
prick test (McNemar χ2=52.3; P<0.0001).
Table 1. Evidence of allergen-specific IgE on skin tests 
(n=745) and RAST (n=693) and agreement between the two 
methods
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Medications and management
Oral antihistamines had been used in the preceding 12 
months by 45.7% of subjects reporting nasal allergies, 
including hayfever. This was significantly more than the 
14.6% use among subjects not reporting such allergies
(χ2=41.2; P<0.0005). Allergen immunotherapy
('vaccination for allergy') had been attempted at some 
time by 12.4% of subjects reporting nasal allergies 
compared with 1.5% of those not reporting such allergies
(χ2=38.6; P<0.0005).
Risk factors for nasal allergies, including 
hayf ever
Subjects who reported nasal allergies, including hayfever, 
are compared with those who did not report such allergies 
in Table 2. Females, non-smokers and those with a family 
history of allergies, current asthma (see earlier), a history of 
eczema and nasal symptoms induced by dust, pollen or 
food were significantly more likely to have nasal allergies. 
Age, country of birth, parental smoking during childhood, 
keeping cats, dogs or birds, household mold, fuels used 
for heating, hot water and cooking were not related to 
nasal allergies. Although pets kept during childhood were 
generally unrelated, hamsters had been kept by 0.6% of 
those who reported nasal allergies, compared with 2.4% 
of those who did not report nasal allergies (Fisher's exact 
test P=0.046).
 Not surprisingly, atopy was a strong risk factor for nasal 
allergies, including hayfever. Subjects with any positive 
skin test were 6.1-fold (95% Cl 4.5-8.3) more likely to 
report nasal allergies. The greatest risks were associated 
with skin reactivity to birch, Timothy grass, plantain, olive, 
Cladosporium or rye grass pollen in that order. The risks 
associated with skin reactivity to indoor allergens, such as 
cat, D. pteronyssinus and Alternaria, were less, but were 
still significantly elevated (Fig. 1). Although subjects with
Table 2. Comparison of demographic characteristics, 
smoking, family history, asthma, eczema and nasal symptoms 
between young adults reporting and those not reporting nasal 
allergies, including hayfever (n=876)
Fig. 1 Risk (bivariate odds ratios and 95% confidence intervals) of nasal allergies, including hayfever, in relation to positive skin 
prick tests to Specific allergens (n=745).
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Table 3 Significant independent predictors of nasal 
allergies, including hayfever, in young adults by multiple 
logistic regression (n=707)
positive skin tests to Parietaria or ragweed were more 
likely to report nasal allergies, their numbers were small 
and the risks did not reach statistical significance. 
 Total serum IgE was significantly higher among 
subjects reporting nasal allergies, including hayfever, 
than among those who did not report such allergies 
(geometric mean 86.7 vs 25.3kU/L; P<0.0001). There 
were similar findings for allergen-specific IgE, although 
there were a few qualitative differences between RAST 
and skin tests. There were significant monotonic 
relationships between the prevalence of nasal allergies 
and the level of allergen-specific IgE as reflected by RAST 
class for all allergens tested (data not shown). This was 
true even for ragweed and Cladosporium. However, there 
was a decline in nasal allergy prevalence among subjects 
with a moderately positive Cladosporium RAST, probably 
an artefact of small numbers.
 A multivariate model of nasal allergies including 
hayfever is summarized in Table 3. The sample size for the 
multiple logistic regression was reduced because of 
missing data, particularly for current asthma. The results 
of skin tests were used to indicate allergen-specific IgE 
rather than RAST, because of their greater sensitivity. The 
significant independent predictors were positive skin tests 
to Timothy grass pollen, house dust mite and plantain, 
current asthma, a history of eczema or skin allergies and 
female gender. Current smoking was associated with a 
lower risk of nasal allergies. Age, family history, early 
respiratory infection, the results of skin tests with other 
aeroallergen extracts and total serum IgE did not enter the 
model.
DISCUSSION
This study has confirmed the extremely high prevalence of 
nasal allergies among young adults in Melbourne. 
Indeed, the proportion of all subjects who reported 
symptoms consistent with hayfever (40.4%) is very close
to that previously found in the Tasmanian cohort study.2 In 
contrast, hayfever was less commonly reported by 
respondents in the Australian National Health Survey,1 
which used a more representative sampling strategy, 
including older subjects and those resident outside 
capital cities.
 The addition to our sample of subjects with symptoms 
of asthma inflated the estimated prevalence of nasal 
allergies from 47.5 to 53.3%. We have previously found 
some evidence of non-response bias in that randomly 
selected subjects who returned the postal survey promptly 
were more likely to report wheeze, asthma or nasal 
allergies than those who only responded after repeat 
mailings or telephone follow-up.18 The overall prevalence 
of nasal allergies, including hayfever, among all 3200 
respondents to the postal survey was 41.0%,13 suggesting 
that those with nasal allergies were over-represented to 
some extent in the present study.
 Notwithstanding these biases, the prevalence of 
allergic rhinitis still appears to be higher in Australia than 
in many other countries. Allergic rhinitis was reported by 
only 4.5% of adults in Singapore,19 2.1 % of secondary 
students in China, 11.2% of secondary students in 
Malaysia and 15.7% of secondary students in Hong 
Kong,20 14.2% of adults in Switzerland21 and 16.4% of 
adults in Colombia.22 The Dutch component of the 
ECRHS found that 29.5% of adults between 20 and 70 
years of age reported nasal symptoms.23 While it is 
tempting to speculate that these differences are related to 
climate, local pollens, indoor allergens, lifestyle or 
economic development, the findings could be seriously 
confounded by different definitions and methodology. A 
more complete explanation awaits the final international 
analysis of the full ECRHS data set.
 The greater sensitivity of skin tests compared with RAST 
(even using the Pharmacia CAP system) to detect low 
titers of allergen-specific IgE has been previously 
observed.24 However, we found the opposite in relation to 
ragweed-specific IgE, which was much more readily 
detected in vitro than by skin test. Unlike North America, 
ragweed is not a major allergen in Melbourne. The 
ragweed PhazetsTM had to be specifically imported for this 
study, but it is unlikely that they had lost biological 
potency by the time of testing. The most likely explanation 
for this discrepancy lies in some antigenic difference 
between the batch of ragweed allergen in the 
immun CAP and that used to coat the ragweed PhazetTM. 
The Dutch ECRHS group have recently suggested that 
skin tests and RAST may provide complementary 
information in diagnosing allergic rhinitis.23
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 Our study confirms that oral antihistamines are widely 
used in Australia for the control of nasal symptoms. In the 
National Health Survey, 83.3% of persons who reported 
hayfever took medication for allergy, 65% of which was 
fully prescribed.1 In contrast, 54% of hayfever sufferers in 
Nottingham, UK, used over-the-counter treatments and 
one-third said that they felt drowsy after using them.5 The 
newer non-sedating antihistamines, such as terfenadine, 
astemizole and loratidine, are now available over the 
counter without prescription in Australia. It is interesting 
that 14.6% of our subjects without nasal allergies reported 
using antihistamines, presumably for other conditions, 
such as eczema, insect allergy, motion sickness and 
urticaria.
 Allergen immunotherapy is used for the prophylaxis of 
seasonal allergic rhinitis. The benefit of controlling nasal 
symptoms and reducing medication must be weighed 
against the small risk of life-threatening anaphylactic 
reactions to aqueous allergen extracts. The depot 
allergen preparations generally used in Australia have 
not been associated with anaphylaxis. The retrospective 
nature of our data does not really permit any valid 
assessment of the efficacy or safety of immunotherapy for 
allergic rhinitis. Immunotherapy was also reported by a 
few subjects without allergic rhinitis who had been treated 
for other conditions, such as asthma or eczema.
 Some of the risk factors for allergic rhinitis identified in 
this analysis were already recognized. Although some 
previous studies have not found any difference in 
hayfever prevalence between males and females,21,25 the 
Dutch ECRHS group has also found that nasal symptoms 
are more common in women.23 The familial nature of the 
condition and the strong associations with other allergic 
disorders, such as eczema and asthma, are well 
known.4,9,10 Exposure to allergens from animals, feathers 
or dust, trees, grass, plants, flowers or pollen and eating 
particular foods were confirmed as common trigger 
factors for nasal symptoms in Australia. The relationship 
between these environmental triggers and nasal 
symptoms persisted after controlling for asthma. In fact, 
nasal symptoms related to food were largely confined to 
those subjects without asthma.
 There were a couple of surprising findings in the 
present study. Although also found by the Dutch 
investigators,23 it is unlikely that smoking actually reduces 
the risk of nasal allergies. It is more probable that 
subjects with nasal allergies are unable to tolerate the 
odor of tobacco smoke. Indeed, Sibbald and Rink4 found 
that subjects with seasonal rhinitis were less likely to have
a smoker in the household. While people who keep 
hamsters are unlikely to be significantly protected from 
the evelopment of nasal allergies, it is possible that 
families with allergic children may be less likely to have 
fur y pets. However, other studies have not found any 
consistent relationship between keeping pets and allergic 
rhinitis.19
 Atopy is clearly an important factor in the development 
of nasal allergies, including hayfever, in young adults. As 
previously found,4,11,25 the association is strongest with 
sensitization to outdoor allergens, such as pollens, and 
less, although still significant for indoor allergens. We 
found dose-response relationships between the titers of 
allergen-specific IgE and the prevalence of nasal 
allergies, which is some evidence of causality. However, 
the postulated temporal sequence of allergen exposure, 
atopic sensitization and clinical disease cannot really be 
established by a single cross-sectional study.
 One potential weakness of the present study was the 
wording of the key question, which made it very difficult to 
distinguish between seasonal and perennial allergic 
rhinitis. This is reflected in the final multivariate model, 
where sensitization to Timothy grass, plantain and house 
dust mites were all significant independent predictors. 
The failure of sensitization to other allergens to enter the 
model presumably represents allergenic cross-reactivity, 
as the risk estimates for positive skin tests to birch, olive, 
Cladosporium and rye grass were of similar magnitude. 
Although strongly associated with nasal allergies, 
including hayfever, in bivariate analyses, a family history 
of allergies was no longer a significant predictor after 
allowing for the effects of atopy, asthma and eczema.
  Further research into the environmental causes of 
allergic rhinitis will require cohort studies with 
prospective measurement of allergen exposure. There is 
a pressing need for generally accepted epidemiological 
definitions of hayfever and perennial allergic rhinitis. 
Future self-report symptom questionnaires should be 
valid ted against objective markers of nasal 
i flammation. Unfortunately, the sensitivity and 
specificity of the available markers, such as non-specific 
nasal challenge and nasal lavage, remain to be 
established in the general population. In addition, the 
key outcome of quality of life should be assessed with 
validated disease-specific questionnaires.3 Only then 
will i be possible to develop and evaluate effective 
public health strategies to reverse the rising prevalence 
and morbidity of allergic rhinitis in Australia and in many 
other Western societies.
NASAL ALLERGIES IN YOUNG ADULTS 219
ACKNOWLEDGEMENTS AND DISCLAIMER
We wish to acknowledge the financial support of Allen+
Hanburys Australia (Boronia, Vic., Australia). Kabi-
Pharmacia of Sweden provided the PhazetsTM and 
reagents for IgE and RAST assays. Christopher Hartley-
Sharpe and Anna Lanigan (Department of Respiratory 
Medicine, Alfred Hospitall) assisted with interviewing and 
testing in the Lung Function Laboratory. These results are 
from a local analysis of data collected for the ECRHS. Any 
final international comparison may use a different form of 
analysis.
REFERENCES
1 Australian Bureau of Statistics. 1989-90 National Health 
   Survey: Asthma and other respiratory conditions. 
   Canberra: Commonwealth Government Printer, 1991; 
   Cat. No. 4373.0. 
2 Hopper JL, Jenkins MA, Carlin JB, Giles GG. Increase in 
   the self-reported prevalence of asthma and hay fever in 
   adults over the last generation: A matched parent-
   offspring study. Aust. J. Public Health 1995; 19: 120-4. 
3 Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of 
   life in adolescents with allergic rhinoconlunctivitis: 
   Development and testing of a questionnaire for clinical 
   trials. J. Allergy Clin. Immunol. 1994; 93: 413-23. 
4 Sibbald B, Rink E. Epidemiology of seasonal and perennial 
   rhinitis: Clinical presentation and medical history. Thorax 
  1991; 46: 895-901. 
5 Richards S, Thornhill D, Roberts H, Harries U. How many 
   people think they have hay fever and what they do about it. 
   Br. J. Gen. Pract. 1992; 42: 284-6. 
6 Burney PGJ, Luczynska C, Chinn S, Jarvis D. The European 
   Community respiratory health survey. Eur. Respir. J. 1994; 
   7: 954-60. 
7 European Community Respiratory Health Survey. 
   Variations in the prevalence of respiratory symptoms in the 
   European Community Respiratory Health Survey. Eur. 
   Respir. J. 1996; 9: 687-95. 
8 Leung RC, Carlin JB, Burdon JG, Czarny D. Asthma, 
   allergy and atopy in Asian immigrants in Melbourne. Med. 
   J. Aust. 1994; 161: 418-25. 
9 Dold S, Wjst M, Von Mutius E, Reitmeir P, Stiepel E. Genetic 
   risk for asthma, allergic rhinitis, and atopic dermatitis. 
  Arch. Dis. Child. 1992; 67: 1018-22. 
10 Bener A, al-Jawadi TQ, Simsek M, al-Nassar KE. Heredity 
   of asthma in Saudi population. Eur. J. Epidemiol. 1992; 8: 
   733-6.
11 Charpin D, Hughes B, Mallea M et al. Seasonal allergic 
   symptoms and their relation to pollen exposure in south-
   east France. Clin. Exp. Allergy 1993; 23: 435-9. 
12 Annesi I, Oryszczyn MP, Neukirch F et al. Relationship of 
   upper airways disorders to FEV1 and bronchial 
   hyperresponsiveness in an epidemiological study. Eur. 
   Respir. J. 1992; 5: 1104-10. 
13 Abramson M, Kutin J, Czarny D, Walters EH. The 
   prevalence of asthma and respiratory symptoms among 
   young adults: Is it increasing in Australia? J. Asthma 1996; 
   33: 189-96. 
14 Abramson M, Kutin JJ, Raven J, Lanigan A, Czarny D, 
   Walters EH. Risk factors for asthma among young adults in 
   Melbourne, Australia. Respirology 1996; 1: 291-7. 
15 belle BG, Peat JK, Salome CM, Mellis CM, Woolcock AJ. 
   Toward a definition of asthma for epidemiology. Am. Rev. 
   Respir. Dis. 1992; 146: 633-7. 
16 SAS Institute Inc. SAS/STAT user's guide, release 6.03 edn. 
   Cary: SAS Institute Inc., 1988. 
17 Rosner B. Fundamentals of biostatistics, 3rd edn. Boston: 
   DWS-Kent. 1990. 
18 Kutin J, Abramson M, Raven J, Lanigan A, Czarny D, 
   Walters EH. Non responders and volunteers: Can't live 
   with them, can't live without them. Am. J. Respir. Crit. Care 
   Med. 1995; 151: A567. 
19 Ng TP, Tan WC. Epidemiology of allergic rhinitis and its 
   associated risk factors in Singapore. Int. J. Epidemiol. 
   1994; 23: 553-8. 
20 Leung R, Ho P. Asthma, allergy and atopy in three south-
   east Asian populations. Thorax 1994; 49: 1205-10. 
21 Wuthrich B, Schindler C, Leuenberger P, Ackermann-
   Liebrich U. Prevalence of atopy and pollinosis in the adult 
   population of Switzerland. (SAPALDIA study) Swiss Study on 
   Air Pollution and Lung Diseases in Adults. Int. Arch. Allergy 
   Immunol. 1995; 106: 149-56. 
22 Caraballo L, Cadavid A, Mendoza J. Prevalence of asthma 
   in a tropical city of Colombia. Ann. Allergy 1992; 68: 
   525-9. 
23 Droste JHJ, Kerkhof M, de Monchy JGR, Schouten JP, 
   Rilcken B and the Dutch ECRHS Group. Association of skin 
   test reactivity, specific IgE, total IgE and eosinophils with 
   nasal symptoms in a community based population study. J. 
   Allergy Clin. Immunol. 1996; 97: 922-32. 
24 Abramson M, Pearson L, Kutin J, Czarny D, Dziukas L, 
    Bowes G. Allergies, upper respiratory tract infections and 
   asthma. J. Asthma 1994; 31: 367-74. 
25 Sears MR, Burrows B, Flannery EM, Herbison GP, 
   Holdaway MD. Atopy in childhood. I. Gender and allergen 
   related risks for development of hay fever and asthma. 
   Clin. Exp. Allergy 1993; 23: 941-8.
